HIV/AIDS News Media Resources
Leading HIV Experts Convene 2019 National HIV Prevention Conference – March 18, 2019
In support of the conference theme – Getting to No New Infections – speakers, including U.S. Secretary of Health and Human Services Alex M. Azar II, CDC Director Robert R. Redfield, M.D., National Institute of Allergy and Infectious Diseases Director Anthony S. Fauci, M.D., Health Resources & Services Administration HIV/AIDS Bureau Associate Administrator, Laura Cheever, M.D., and NCHHSTP Director Jonathan Mermin, M.D., will share their vision and insights on the coordinated federal effort to eliminate HIV in the United States within a decade: Ending the HIV Epidemic: A Plan for AmericaExternal.
CDC Vital Signs: HIV Transmission along the Continuum of Care, 2016 – March 18, 2019
Published on the first day of CDC’s 2019 National HIV Prevention Conference, a new CDC Vital Signs report provides the latest data on the impact of undiagnosed and untreated HIV in the nation and underscores the critical need to expand HIV testing and treatment in the U.S.
2019 Conference on Retroviruses and Opportunistic Infections – March 7, 2019
A new CDC analysis presented today at the Conference on Retroviruses and Opportunistic Infections in Seattle, Washington finds more gay and bisexual men at high risk for HIV are using pre-exposure prophylaxis (PrEP), but significant gaps remain – especially among African Americans and Latinos.
Progress in HIV prevention has stalled; need for immediate action — ‘Ending the Epidemic: A Plan for America’ – February 27, 2019
Annual HIV infections (“HIV incidence”) in the United States have been reduced by more than two-thirds since the height of the epidemic in the mid-1980s, but CDC data indicate that progress has stalled in recent years. Following about five years of declines, the estimated number of new HIV infections began to level off in 2013 at about 39,000 per year — reinforcing the need for more action to end America’s HIV epidemic. The report also finds that new HIV infections declined in some populations, but increased in others.
2018 Conference on Retroviruses and Opportunistic Infections – March 6, 2018
A new CDC analysis presented today at the Conference on Retroviruses and Opportunistic Infections in Boston, Mass., suggests only a small percentage of Americans who could benefit from pre-exposure prophylaxis (PrEP) have been prescribed it. Furthermore, while two-thirds of people who could potentially benefit are African American or Latino, they account for the smallest percentage of PrEP prescriptions to date. Additionally, two new CDC analyses presented at CROI demonstrate the effectiveness of SSPs and HIV testing and treatment in helping to end a large outbreak of HIV among people who inject drugs (PWID).
CDC Vital Signs: HIV Testing and Diagnosis Delays – November 28, 2017
A new CDC Vital Signs report finds that HIV testing has improved, and that HIV is being diagnosed sooner after infection – but many people still have HIV for years before they know it.
CDC’s comprehensive analysis of the U.S. HIV care continuum shows that, based on the most recent national data from 2014, of the estimated 1.1 million people living with HIV in the United States, 85% knew they were infected, and about half (49%) were virally suppressed. The analysis also details differences in HIV diagnosis, care and treatment by age, race / ethnicity, transmission route, and sex.
2017 Conference on Retroviruses and Opportunistic Infections – February 15, 2017
CDC released estimates of the number of annual HIV infections (HIV incidence) in the United States – overall and by transmission group – at the Conference on Retroviruses and Opportunistic Infections on Feb. 14, 2017, in Seattle. These estimates provide the most up-to-date picture of HIV trends in the United States. Additionally, research from a joint study by The Rollins School of Public Health at Emory University and CDC suggests that for gay and bisexual men, pre-exposure prophylaxis (PrEP) for HIV prevention, along with testing for and treatment of sexually transmitted infections (STIs), can reduce not only HIV, but also some STIs, even in the presence of some reductions in condom usage.
CDC Vital Signs: HIV and Injection Drug Use – November 29, 2016
Use of syringe services programs has increased substantially during the last decade, but most people who inject drugs are still not using sterile needles consistently, according to a new CDC Vital Signs report.
2016 International AIDS Society Conference: New Research on HIV Risk Behaviors in Gay, Bisexual Male High School Students – July 20, 2016
New CDC data presented today at the International AIDS Conference in Durban, South Africa, suggests there are no significant differences in several HIV-related risk behaviors among male students in ninth through 12th grades who identify as heterosexual, gay or bisexual.
2016 Conference on Retroviruses and Opportunistic Infections – February 23-24, 2016
CDC researchers will be presenting findings from more than 40 studies in Boston, Massachusetts from February 22-25, 2016 on the latest developments in the prevention and treatment of HIV and related infectious diseases.
CDC Statement on Syringe Services Programs – December 21, 2015
Statement from Dr. Jonathan Mermin, Director, CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, regarding Congress giving states and local communities the opportunity to use federal funds to support certain aspects of syringe services programs.
- The number of new HIV infections in the U.S. has stabilized in recent years – new infections began to level off in 2013 at about 39,000 per year.
- African Americans and gay & bisexual men face a heavier burden of HIV and are at higher risk for infection.
Eugene McCray, MD
Director, Division of HIV/AIDS Prevention
View Dr. McCray's full bio